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Abstract 
Prostaglandins (PGs) play a key role in the development on the immune response, 
through the regulation of both pro- and anti-inflammatory processes. PGD2 can be either pro- 
or anti-inflammatory depending on the inflammatory milieu. Prostaglandin D synthethase 
(PGDS) is the enzyme responsible for the conversion of PGH2 to PGD2. In mammals, two 
types of PGDS synthase have been described, the hematopoietic (H-PGDS) and the lipocalin 
(L-PGDS). In the present study we describe the existence of two orthologues of the 
mammalian L-PGDS (PGDS1 and PGDS2) in the gilthead seabream and characterize their 
gene expression profiles and biological activity. The results showed a dramatic induction of 
the gene coding for PGDS1 in acidophilic granulocytes (AGs), which are functionally 
equivalent to mammalian neutrophils, after a prolonged in vitro activation with different 
pathogen associated molecular patterns (PAMPs). In contrast PGDS2 was not expressed in 
these cells. The functional relevance of the induction of PGDS1 in AGs was confirmed by the 
ability of these cells to release PGD2 upon PAMP stimulation. To gain further insights into 
the role of PGD2 in the resolution of inflammation in fish, we examine the ability of PGD2 or 
its cyclopentenona derivates (cyPGs) to modulate the main functional activities of AGs. It 
was found that both PGD2 and cyPGs inhibited the production of reactive oxygen species and 
downregulated the transcript levels of the gene encoding interleukin-1. Altogether, these 
results demonstrate that the use of PGD2 and its metabolites in the resolution of inflammation 
was established before the divergence of fish from tetrapods more than 450 million years ago 
and support a critical role for granulocytes in the resolution of inflammation in vertebrates. 
Free Keywords: prostaglandins, neutrophils, acidophilic granulocytes, seabream, teleosts. 
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Introduction 
Eicosanoids, including prostaglandins (PGs), leukotrienes (LTs) and lipoxins (LXs) 
are small fatty acid molecules derived from polyunsaturated fatty acids released from the cell 
membrane phospholipids, mainly araquidonic acid. Prostaglandins play a significant role in 
the progress of the immune response at multiple levels, often in concert with microbial 
ligands, cytokines, chemokines, and various other factors (Hirata and Narumiya, 2012).  
The first enzyme involved in PG biosynthesis is the cyclooxygenase (COX) which 
converts araquidonic acid to PGH2. There are several forms of COX: the COX-1 is 
constitutively expressed in nearly all cell types, while COX-2 is mainly inducible in 
inflammatory conditions and only expressed by a more limited range of cell types (Simmons 
et al., 2004). PGH2 is subjected to further conversion to give rise to the PG generation 
including PGE2 and PGD2. (Joo and Sadikot, 2012). PGD2 is converted to cyPGs, i.e. 15-
deoxy-12,14 PGJ2 and 12PGJ2, by albumin-independent and dependent reactions, 
respectively (Shibata et al., 2002). 
PGD2 synthase is the responsible for the production of PGD2 (the major prostaglandin 
in the central nervous system and in immune cells) from PGH2. In the most evolutionary 
organisms, two distinct types of PGD2 synthases have been identified: the hematopoietic form 
(H-PGDS) and the lipophilic ligand-carrier protein (lipocalin)-type enzyme (L-PGDS). These 
two enzymes share no homology in DNA and polypeptide sequences (Kanaoka et al., 1997) 
and show different tissue expression profiles, being L-PGDS mainly expressed in the CNS 
and related organs (Urade and Hayaishi, 2000) and H-PGDS in hematopoietic cells, including 
macrophages (Urade and Eguchi, 2002). Previous studies have reported an important role for 
H-PGDS in the control of the onset and resolution of acute inflammation (Rajakariar et al., 
2007). However, while H-PGDS is constitutively expressed in macrophages, the L-PGDS is 
not detected in macrophages in normal conditions but expressed in a pathological 
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environment (Cipollone et al., 2004). The production of PGD2 by neutrophils has been 
controversial. Pouliot and coworkers  reported that the main PGH2derived metabolites 
produce in vitro by human neutrophil following activation with several inflammatory stimuli 
were TXB2 and PGE2, whereas they did not observed a detectable level of PGD2 (Pouliot et 
al., 1998). However, two more recent studies have shown the production of PGD2 by human 
neutrophils during spontaneous apoposis (Brown et al., 2003) and by mouse neutrophils 
during acute lung injury (Murata et al., 2013). Strikingly, H-PGDS was responsible for the 
production of PGD2 by mouse neutrophils (Murata et al., 2013). 
Taking into account that fish express several isoforms of L-PGDS, but none for H-
PGDS, the aim of this study was to determine the role of PGDSs and their products, PGD2
and cyPGDs, in the resolution of inflammation in the teleost fish gilthead seabream (Sparus 
aurata L.) and, in particular the contribution of acidophilic granulocytes (AGs), which are 
functionally equivalent to mammalian neutrophils (Cabas et al., 2013; Chaves-Pozo et al., 
2005; Chaves-Pozo et al., 2004; Sepulcre et al., 2007; Sepulcre et al., 2011; Sepulcre et al., 
2002), to the production of PGD2.  
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Materials and Methods 
Animals 
Healthy specimens (150 g mean weight) of the hermaphroditic protandrous marine 
fish gilthead seabream (Sparus aurata, Actinoperygii, Sparidae) were bred and kept at the 
Oceanographic Centre of Murcia (Spain) in a 14 m3 running seawater tank (dissolved oxygen 
6 ppm, flow rate 20% tank volume/hour) with natural temperature and photoperiod, and fed 
twice a day with a commercial pellet diet (Skretting, Burgos, Spain). Fish were fasted for 24 
hours before sampling. The experiments performed comply with the Guidelines of the 
European Union Council (86/609/EU) and the Bioethical Committee of the University of 
Murcia (Spain) for the use of laboratory animals.  
Isolation of phagocytes 
AGs were obtained by MACS as described earlier (Roca et al., 2006). Briefly, head 
kidney cell suspensions were incubated with a 1:10 dilution of a mAb specific to gilthead 
seabream AGs (G7) (Sepulcre et al., 2002), washed twice with PBS containing 2 mM EDTA 
(Sigma-Aldrich) and 5% FCS (Invitrogen) and then incubated with 100-200 l per 108 cells 
micro-magnetic-bead-conjugated anti-mouse IgG antibody (Miltenyi Biotec). After washing, 
G7+ (AGs) cell fractions were collected by MACS following the manufacturers instructions 
and their purity analyzed by flow cytometry (Roca et al., 2006). 
Cell culture and treatments 
Isolated AGs were stimulated at 23°C with 50 g/ml phenol-extracted genomic DNA 
from Vibrio anguillarum ATCC19264 cells (VaDNA) or 100 ng/ml flagellin (Invivogen) in 
sRPMI [RPMI-1640 culture medium (Gibco) adjusted to gilthead seabream serum osmolarity 
(353.33 mOs) with 0.35% NaCl] supplemented with 0.1% FCS and 100 I.U./ml penicillin and 
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100 g/ml strepomycin (Biochrom). These concentrations of PAMPs have been found to be 
optimal for in vitro activation of seabream AGs (Sepulcre et al., 2007). AGs were cultured 
with or without the synthetic stable analog of PGD2 (5-20 M, 16,16-dimethyl PGD2), the 
synthetic stable analog of 13,14-dihydro-15-keto PGD2 (5-20 M, 11-deoxy-11-methylene-
15-keto PGD2), 15-deoxy-12,14 PGJ2 (0.5-1 M) and  12PGJ2 (1-10 M) (Cayman 
Chemical). 
In vivo sampling and experimental infections 
Fish were injected intraperitoneally with 1ml of phosphate-buffered saline (PBS) alone 
or containing a sublethal dose (108) of exponentially growing V. anguillarum R82 cells 
(Chaves-Pozo et al., 2004). Head kidney, spleen, thymus, liver, gills, blood and peritoneal 
exudates cells were obtained 4 h after bacterial challenge. Gut and brain were obtained from 
PBS treated fishes. All samples were processed for subsequent real-time RT-PCR (see 
below). 
Analysis of gene expression 
Total RNA was extracted as indicated above and treated with DNase I, Amplification 
grade (1 unit/µg RNA, Life technologies). The SuperScrip III RNase H- ReverseTranscripase 
(Life technologies) was used to synthesize first strand cDNA with oligo-dT18 primer from 1 
µg of total RNA at 50 ºC for 50 min. Real-time PCR was performed with an ABI PRISM 
7500 instrument (Applied Biosystems) using SYBR Green PCR Core Reagents (Applied 
Biosystems). Reaction mixtures were incubated for 10 min at 95ºC, followed by 40 cycles of 
15 s at 95ºC, 1 min at 60ºC, and finally 15 s at 95ºC, 1 min 60ºC and 15 s at 95ºC. For each 
mRNA, gene expression was corrected by the by the ribosomal protein S18 (rps18) content in 
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each sample using the comparative Ct method (2-Ct). The primers used are shown in Table 
1. In all cases, each PCR was performed with triplicate samples and repeated at least twice.  
Measurement of PGD2 by EIA 
Evaluation of PGD2 was synthesis were performed by analyzing supernatants from 
AGs stimulated or not with VaDNA for one to 3 days using a commercial enzyme 
immunoassay (EIA) kit (Cayman Chemical). 
Cell viability 
Aliquots of cell suspensions were diluted in 200 l PBS containing 40 g/ml 
propidium iodide (PI). The number of red fluorescent cells (dead cells) from triplicate 
samples was analyzed by using flow cytometry. 
Respiratory burst assays 
Respiratory burst activity was measured as the luminol-dependent chemiluminescence 
produced by AGs after different times of stimulation (Mulero et al., 2001). This was brought 
by adding 100 M luminol and 1 g/ml PMA (both from Sigma-Aldrich), while the 
chemiluminescence was recorded every 117 seconds for 1 h in a FLUOstart luminometer 
(BGM, LabTechnologies). The values reported are the average of quadruple readings, 
expressed as the slope of the reaction curve from 117 to 1170 seconds, from which the 
apparatus background was subtracted. 
Statistical analysis 
Data were analyzed by ANOVA and a Tukeys multiple range test to determine 
differences between groups. 
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RESULTS  
Identification of genes encoding PGDS in gilthead seabream 
Searches within publicly available EST database of the European Nucleotide Archive 
(ENA) allowed us to identify two genes encoding for gilthead seabream PGDS1 and PGDS2 
(ENA accession numbers AM971774 and AM959591, respectively) (Fig. S1). An interesting 
difference between them was the presence of two ATTTA motifs in the 3 untranslated region 
(UTR) of the PGDS1. These motifs have been shown to be responsible for the unstability of 
mammalian (Han et al., 1990) and fish (Roca et al., 2007) cytokine mRNAs. Both cDNAs 
encoded a single open reading frame which translated into putative 184 and 180 amino acid 
polypeptides, which showed 42.8% (PGDS1) and 46.1% (PGDS2) amino acid similarity to 
human L-PGDS. Alignment of the amino acid sequences deduced for both seabream PGDSs 
with non-mammalian homologous protein sequences deposited in the NCBI databases showed 
significant homologies to the lipocalin protein family (Figure 1). Previous studies showed that 
non-mammalian (zebrafish, xenopus and chicken) and mammalian L-PGDS formed an L-
PGDS sub-family in the lipocalin gene family (Fujimori et al., 2006). One of the features of 
this family is the presence of conserved folding patterns and three structurally conserved 
regions (SCRs) (Flower, 1993). Strikingly, however, zebrafish, rainbow trout and seabream 
L-PGDS all lacked in their primary structure the essential cysteine residue required for PGDS 
activity found in mammalian L-PGDS (Bayne et al., 2001; Fujimori et al., 2006; Urade et al., 
1995).  
PGDS1 gene expression is induced upon AG activation 
As the production of PGD2 by mammalian neutrophils is controversial (Brown et al., 
2003; Joo et al., 2007; Pouliot et al., 1998) , we analyzed the expression of PGDS1 and 
PGDS2 by RT-qPCR in seabream AGs, which are functionally equivalent to mammalian 
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neutrophils (Cabas et al., 2013; Chaves-Pozo et al., 2005; Chaves-Pozo et al., 2004; Sepulcre 
et al., 2007; Sepulcre et al., 2011; Sepulcre et al., 2002), following stimulation in vitro with 
different PAMPs. The results showed that VaDNA or flagellin stimulation resulted in a 
gradual increase of the mRNA levels of PGDS1 along the time of stimulation (Fig. 2a). 
Notably, PGDS2 was not expressed in control or stimulated AGs (data not shown). It is 
important to note that the expression of the genes encoding prostaglandin-endoperoxide 
synthase 2 (PTGS2 or COX2), the limiting enzyme in PGs production (Fig. 2b), and 
interleukin-1 (IL-1) (Fig. 2c) also showed a dramatic up-regulation but with different 
kinetics; peaking at the shortest time analyzed (1 day post-stimulation).  
AGs produce PGD2 following stimulation with PAMPs  
The expression data obtained in AGs, together with the fact that previous reports have 
shown that non-mammalian L-PGDSs have no, or very weak, PGDS activity (Fujimori et al., 
2006) prompted us to analyze the production of PGD2 by these cells. The results showed that 
AGs were able to produce PGD2 in vitro and this production was significantly increased in 
response to stimulation with VaDNA (Fig.3).  
PGD2 and its derivates inhibit AG functions 
We next sought to determine the activity of PGD2 in the main AG functions, i.e. the 
production of reactive oxygen species (ROS) and cytokines. We used 16,16dimethyl-PGD2, 
a metabolically stable synthetic analogue of PGD2 that signals through DP1 receptor (Gervais 
et al., 2001), and the chemically stable ligand of 13,14-dihydro-15-keto-PGD2 of the PGD2 
metabolite 11-deoxy-11-methylene-15-keto-PGD2, which signals via the chemokine-related 
CRTH2 receptor (Hirai et al., 2001). It was found that physiological concentrations of both 
compounds inhibited in a dose-dependent manner the induction of ROS upon VaDNA 
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stimulation (Figs. 4a and 4b). However, cell viability was unaffected (data not shown). It is 
important to note that the effects of 11-deoxy-11-methylene-15-keto-PGD2 on ROS 
production was weaker than that of 16,16dimethyl-PGD2. Similarly, only 16,16dimethyl-
PGD2 was able to inhibit the induced mRNA levels of IL-1 in response to VaDNA (Fig. 4c). 
In the view of these results, we also analyzed the effect of the cyPGs, 15-deoxy-12,14PGJ2 
and 12PGJ2, in AGs activities. Similar to PGD2, both cyPGs decreased ROS production in a 
dose-dependent manner (Figs. 5a and 5b) and downregulated IL-1 expression by AGs (Fig. 
5c). It is important to note that cyPGs exert their effects at lower doses and were more potent 
in comparison with PGD2. Collectively, all these results indicate that PGD2 and its derivates 
have a potent anti-inflammatory effect and suggest an important role of PGD2 released by 
seabream AGs in the resolution of inflammation.  
In vivo expression of seabream PGDSs and modulation upon bacterial infection  
The analysis of the constitutive expression of seabream PGDSs genes showed that 
both genes were expressed in all tissue examined, including key immune organs, like head-
kidney, spleen, thymus and gills, with the exception of PGDS2 in the gut (Figs. 6a and 6b). It 
is important to note that the highest mRNA levels of PGSD1 were found in liver, while those 
of PGDS2 were much higher in brain, gill and thymus.  
To determine whether seabream PGDS might be involved in bacterial infection, 
healthy seabream juveniles were challenged with the fish pathogenic bacterium V. 
anguillarum and then the expression of the gene encoding PTGS2, PGDS1 and PGDS2 were 
all analyzed. Notably, bacterial infection led to an increase in the mRNA levels of PTGS2 and 
PGSD1 in most of the tissues examined; being the blood the tissue where the increase was 
found to be the highest for the two genes (Figures 7a and 7b). In contrast, the mRNA levels of 
PGDS2 did not significantly changed (peritoneal exudates and liver), or even decreased 
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(head-kidney, thymus and gill), after the bacterial challenge, with the exception of the blood 
(Figure 7c). All these data further support a role for PGDS1 in the resolution of the 
inflammatory response in the gilthead seabream. 
Discussion 
PGDS is the enzyme responsible of the conversion of PGH2 to PGD2. Two types of 
PGDS synthase have been described, the hematopoietic (H-PGDS) and the lipocalin (L-
PGDS). This in silico work has revealed the existence of two L-PGDS orthologues in gilthead 
seabream (PGDS1 and PGDS2). In addition, H-PGDS orthologues have not been identified so 
far in the fish genomes available, including ancient, i.e. the zebrafish (Cypriniformes), and 
most evolutionary advance, i.e. pufferfish (Tetraodontiformes), teleost fish. All these data 
point to L-PGDS as the responsible of PGD2 synthesis in gilthead seabream. In addition, the 
results of the tissue distribution of both L-PGDS genes suggest different roles for these two 
molecules. In this context, in the view of that the highest levels of expression PGDS2 were 
found in the brain, together with its weak modulation after bacterial challenge, and taking into 
consideration that mammalian L-PGDS is mainly expressed in CNS and related organs 
(Taniike et al., 2002; Urade et al., 1993), seabream PGDS2 might be considered functionally 
equivalent to mammalian L-PGDS.  
A pro-inflammatory role of L-PGDS has been reported in models of allergic 
inflammation (Satoh et al., 2006) and other inflammation models (Hokari et al., 2011; Nagata 
et al., 2009; Ogawa et al., 2006; Uehara et al., 2009). Other studies have shown using gain 
and loss of function strategies in mice an important role for L-PGDS in the innate immune 
response (Joo et al., 2007; Joo and Sadikot, 2012). Here we have shown the induction of 
PGDS1 and PGDS2 expression in different tissues of seabream challenged with V. 
anguillarum, but with different patterns, being in both cases the blood the tissue where the 
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changes were more evident. The modulation of the expression of PGDS1 and PGDS2 by 
bacterial challenge was weaker in comparison with the changes observed in the mRNA levels 
of PTGS2, which is upstream in the prostanoid biosynthesis pathway. This means that other 
PGH2 derivates could be involved in the clearance of the bacteria and resolution of the 
infection. Collectively, these results suggest that mainly seabream PGDSs would contribute to 
host defense against bacterial infection. 
Previous studies have shown the contribution of L-PGDS in the production of PGD2
by macrophages stimulated with LPS or bacterial infection (Joo et al., 2007). However no 
reports exist about the contribution of L-PGDS in the production of PGD2 by neutrophils. 
Accumulating evidence suggests that seabream AGs could be considered the cell functional 
equivalent to mammalian neutrophils (Cabas et al., 2013; Chaves-Pozo et al., 2005; Chaves-
Pozo et al., 2004; Sepulcre et al., 2007; Sepulcre et al., 2011; Sepulcre et al., 2002). We 
demonstrate herein that AGs do not express PGDS2 constitutively or after stimulation with 
PAMPs. However, VaDNA or flagellin stimulation induced PGDS1 expression in AGs in a 
time dependent manner. In contrast, the induction of the expression of PTGS2 in AGs occurs 
early after stimulation with VaDNA or flagellin. This data are consistent with the observations 
made by Joo et al. (2007) showing that macrophages stimulated with LPS express PTGS2 
before L-PGDS expression by differentially using key transcription factors (NF-B and AP-1, 
respectively), ensuring that a sufficient amount of PGH2 is available for L-PGDS to produce 
PGD2 (Joo et al., 2007). In agreement with this, the expression of IL-1, which is also 
modulated by NF-B, showed the same kinetics than PTGS2. 
L-PGDS is a bifunctional protein, acting as a PGD2 producing enzyme an also as an 
intercellular transporter of lipophilic molecules (Fujimori et al., 2006). Previous studies have 
shown that both zebrafish and chicken PGDSs lack enzymatic activity, while they are able to 
bind thyroxine and all-trans retinoic acid, like mammalian L-PGDSs and other lipocalin gene 
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family proteins (Fujimori et al., 2006). However, the role of this amino acid in the activity of 
fish L-PGDS homologues is not clear, since a zebrafish mutant L-PGDS with reconstituted 
cysteine (G59C) also lacks enzymatic activity (Fujimori et al., 2006). Given the induction of 
seabream PGDS1 expression in AGs stimulated with PAMPs, we wondered to determine the 
production of PGD2 by these cells and the contribution of PGDS1 in this process. Our results 
demonstrate that seabream AGs are able to produce PGD2 and this production is increased 
upon stimulation with VaDNA with a similar kinetics than PGDS1 expression. These results 
suggest that PGDS1 may be responsible for the production of PGD2 that, in turn, would be 
involved in the resolution of the inflammatory response in this species. Although further 
studies are needed for determine the role of seabream PGDS1 in this process, it is tempting to 
speculate that it could contribute to PGD2 production by AGs. Nowadays, very few reports 
exist regarding the role of PGD2 production by neutrophils and its role in the resolution of 
inflammation. Taken into account that gilthead seabream AGs are considered the functional 
equivalent to mammalian neutrophils, these results led us to hypothesize that the production 
of PGD2 by neutrophils could be an essential component in the resolution of the inflammation 
in vertebrates. 
The role of PGD2 in immune response is complex because it can elicit pro-
inflammatory and anti-inflammatory effects depending on the inflammatory milieu. In 
addition PGD2 can exert its function by the interaction with two G protein-coupled receptors: 
the D prostanoid recepor 1 (DP1) and the chemoattractant receptor-homologous molecule 
expressed on Th2 cells (CRTH2)(Gervais et al., 2001) . CRTH2 has been shown to be 
expressed in various mouse immune cells, including Th1 cells, Th2 cells, eosinophils, 
monocytes, and neutrophils (Kim and Luster, 2007; Takeshita et al., 2004) In this study, we 
demonstrate that stable synthetic analogues of PGD2 (16,16dimethyl-PGD2) and its derivate 
11-deoxy-11-methylene-15-keto-PGD2, an specific agonist for CRTH2, at micromolar 
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concentrations, decrease the production of ROS by AGs stimulated in vitro with PAMPs. In 
addition, both of them were also able to down-regulate the mRNA levels of IL-1 in 
stimulated AGs. Therefore, these results show that PGD2 produced by stimulated AGs exerts 
an anti-inflammatory effect by their own. Nevertheless, PGD2 is a relative unstable molecule, 
which is readily degraded by a series of spontaneous dehydration and isomerization reactions 
into biologically active prostaglandins of the J2 series, namely PGJ2, 12PGJ2 and 15-deoxy-
12,14 PGJ2, called CyPGs. Therefore, the role of PGD2 in inflammation is complex because 
the net effect may depend on the rate of the production of its distal products. In this regards, 
we demonstrate herein that both CyPGs also exerts anti-inflammatory effects on AGs 
activities by decreasing ROS production and the expression of IL-1. It is noteworthy that 
CyPGs were more potent and exert their effects at lower doses than PGD2. Thus, it is 
tempting to speculate that some of the regulatory effects of PGD2 in the late phases of the 
resolution of the inflammation may also arise from its induction of other families of PGH2
derivates. 
In summary, in this study we provide proof that PGD2, likely produced by PGDS1, 
plays an important role in the resolution of the inflammation in gilthead seabream. In 
addition, we demonstrate that AGs, the cells functionally equivalent to mammalian 
neutrophils, synthesize PGD2 that directly or via the production of its metabolites CyPGs 
regulates the resolution of the inflammatory response by controlling the balance of anti- vs. 
pro-inflammatory mediators as well as by decreasing ROS production. Furthermore our 




We thank Inma Fuentes and Pedro J. Martínez for excellent technical assistance, Drs. AE 
Toranzo and JL Barja (University of Santiago) for the R82 strain of V. anguillarum. 
Footnotes 
1This work was supported by the Spanish Ministerio de Economía y Competitividad (research 
grant AGL2012-39674 to M.P.S.,  PhD fellowship to V.G., and Juan de la Cierva contract to 
J.M., all co-funded with Fondos Europeos de Desarrollo Regional/European Regional 
Development Funds). 
2Abbreviations: acidophilic granulocytes, AGs; PAMPs, pathogen-associated molecular 




Figure 1. Alignment of the amino acid sequences predicted from seabream PGDSs and 
the corresponding zebrafish L-PGDSb and human L-PGDS cDNAs. Amino acid 
sequences predicted from seabream L-PGDS cDNAs were compared with those of known 
zebrafish L-PGDSb and human L-PGDS cDNAs. The Cys residue essential for PGDS activity 
in mammals are emphasized by grey background, and the two Cys residues required for the 
disulfide-bond formation are indicated in bold. Three SCRs (Structural Conserved Regions) 
are indicated by closed squares inside the alignment.  
Figure 2.  PGDS1 expression is induced upon AG activation.  AGs were stimulated for 1, 
3, 6 and 10 days with 50 g/ml VaDNA or 0.1g/ml flagellin in sRPMI supplemented with 
5% FCS and the mRNA levels of pgds1 (A) and pgts2 (B) and il1b (C) were studied by real-
time RT-PCR .The gene expression is normalized against rps18 and expressed as mean±S.E 
of the gene mRNA fold increase in stimulated cells relative to non cultured cells. Different 
letters denote statistically significant differences among the groups according to a Tukey test. 
The groups marked with a did not show statistically significant differences from control 
cells (p<0.05).  
Figure 3. PGD2 production by AGs upon stimulation.  Head kidney AGs were stimulated 
for 1 and 3 days with 50 g/ml VaDNA in sRPMI supplemented with 5% FCS and the 
production of PGD2 was analyzed in the supernatants by ELISA. The data are expressed as 
mean±S.E (n=3). Different letters denote statistically significant differences among the groups 
according to a Tukey test. The groups marked with a did not show statistically significant 
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differences from one day cultured control cells The results are representative of two 
independent experiments. (p<0.05).  
Figure 4. Anti-inflammatory effect of PGD2 in AGs activities. Head kidney AGs were 
incubated for 16 h with the indicated concentrations of 16,16dimethyl-PGD2 (a stable 
synthetic analog of PGD2) (A) or 11-deoxy-methylene-15-keto-PGD2 (a stable synthetic 
analog of 13,14-dihydro-15-keto-PGD2 ) (B), with or without  50 g/ml of VaDNA and their 
respiratory burst activity was measured. The results are representative of six independent 
experiments. The mRNA levels of the gene coding for IL-1 were determined by real-time 
RT-PCR (C). The gene expression is normalized against rps18 and is shown as relative to the 
mean of control cells incubated in medium alone. Different letters denote statistically 
significant differences among the groups according to a Tukey test. The groups marked with 
a did not show statistically significant differences from control cells. The results are 
representative of three independent experiments. (p<0.05).  
Figure 5. Anti-inflammatory effect of PGJ2 in AGs activities. Head kidney AGs were 
incubated for 16 h with the indicated concentrations of 15-deoxy-12,14 PGJ2 (A) or 12PGJ2
(B) with or without  50 g/ml of VaDNA and their respiratory burst activity was measured. 
The results are representative of six independent experiments. The mRNA levels of the gene 
coding for IL-1 were determined by real-time RT-PCR (C). The gene expression is 
normalized against rps18 and is shown as relative to the mean of control cells incubated in 
medium alone. The results are representative of two independent experiments. Different 
letters denote statistically significant differences among the groups according to a Tukey test. 
The groups marked with a did not show statistically significant differences from control 
cells (p<0.05).  
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Figure 6. Ubiquitous tissue expression pattern of seabream PGDSs. The mRNA levels of 
pgds1 (A) and pgds2 (B) were determined by real-time RT-PCR in the indicated tissues of 
control adult specimens. The results are expressed relative to ribosomal protein S18 and as the 
mean ± S.E.M. of triplicate Different letters denote statistically significant differences among 
the groups according to a Tukey test.  
Figure 7. Tissue expression pattern of seabream PG synthesis related genes following 
infection. The mRNA levels of pgds1 (A), pgds2 (B) and ptgs2 (C) were studied by real-time 
RT-PCR in the indicated immune of control specimens or following 4 h challenge with 108
cells of Vibrio anguillarum. The results are expressed as the gene mRNA fold increase in 
infected fish relative to control fish. The results are presented as mean ± S.E.M. from 
triplicate samples. Statistically significant differences from non-infected fish according to a 
Tukey test are shown as: n.s. (not significant), *p<0.05; **p<0.01; ***p<0.001. 
References: 
Bayne, C.J., Gerwick, L., Fujiki, K., Nakao, M., Yano, T., 2001. Immune-relevant (including 
acute phase) genes identified in the livers of rainbow trout, Oncorhynchus mykiss, by means 
of suppression subtractive hybridization. Developmental and comparative immunology 25, 
205-217. 
Brown, J.R., Goldblatt, D., Buddle, J., Morton, L., Thrasher, A.J., 2003. Diminished 
production of anti-inflammatory mediators during neutrophil apoptosis and macrophage 
phagocytosis in chronic granulomatous disease (CGD). J Leukoc Biol 73, 591-599. 
Cabas, I., Rodenas, M.C., Abellan, E., Meseguer, J., Mulero, V., Garcia-Ayala, A., 2013. 
Estrogen Signaling through the G Protein-Coupled Estrogen Receptor Regulates Granulocyte 
Activation in Fish. J Immunol 191, 4628-4639. 
Cipollone, F., Fazia, M., Iezzi, A., Ciabattoni, G., Pini, B., Cuccurullo, C., Ucchino, S., 
Spigonardo, F., De Luca, M., Prontera, C., Chiarelli, F., Cuccurullo, F., Mezzetti, A., 2004. 
 19
Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic 
plaque instability in humans. Arteriosclerosis, thrombosis, and vascular biology 24, 1259-
1265. 
Chaves-Pozo, E., Mulero, V., Meseguer, J., Garcia Ayala, A., 2005. Professional phagocytic 
granulocytes of the bony fish gilthead seabream display functional adaptation to testicular 
microenvironment. J Leukoc Biol 78, 345-351. 
Chaves-Pozo, E., Pelegrin, P., Garcia-Castillo, J., Garcia-Ayala, A., Mulero, V., Meseguer, J., 
2004. Acidophilic granulocytes of the marine fish gilthead seabream (Sparus aurata L.) 
produce interleukin-1beta following infection with Vibrio anguillarum. Cell and tissue 
research 316, 189-195. 
Flower, D.R., 1993. Structural relationship of streptavidin to the calycin protein superfamily. 
FEBS Lett 333, 99-102. 
Fujimori, K., Inui, T., Uodome, N., Kadoyama, K., Aritake, K., Urade, Y., 2006. Zebrafish 
and chicken lipocalin-type prostaglandin D synthase homologues: Conservation of 
mammalian gene structure and binding ability for lipophilic molecules, and difference in 
expression profile and enzyme activity. Gene 375, 14-25. 
Gervais, F.G., Cruz, R.P., Chateauneuf, A., Gale, S., Sawyer, N., Nantel, F., Metters, K.M., 
O'Neill G, P., 2001. Selective modulation of chemokinesis, degranulation, and apoptosis in 
eosinophils through the PGD2 receptors CRTH2 and DP. J Allergy Clin Immunol 108, 982-
988. 
Han, J., Brown, T., Beutler, B., 1990. Endotoxin-responsive sequences control 
cachectin/tumor necrosis factor biosynthesis at the translational level. J Exp Med 171, 465-
475. 
Hirai, H., Tanaka, K., Yoshie, O., Ogawa, K., Kenmotsu, K., Takamori, Y., Ichimasa, M., 
Sugamura, K., Nakamura, M., Takano, S., Nagata, K., 2001. Prostaglandin D2 selectively 
induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-
transmembrane receptor CRTH2. J Exp Med 193, 255-261. 
Hirata, T., Narumiya, S., 2012. Prostanoids as regulators of innate and adaptive immunity. 
Advances in immunology 116, 143-174. 
Hokari, R., Kurihara, C., Nagata, N., Aritake, K., Okada, Y., Watanabe, C., Komoto, S., 
Nakamura, M., Kawaguchi, A., Nagao, S., Urade, Y., Miura, S., 2011. Increased expression 
of lipocalin-type-prostaglandin D synthase in ulcerative colitis and exacerbating role in 
murine colitis. American journal of physiology. Gastrointestinal and liver physiology 300, 
G401-408. 
Joo, M., Kwon, M., Sadikot, R.T., Kingsley, P.J., Marnett, L.J., Blackwell, T.S., Peebles, 
R.S., Jr., Urade, Y., Christman, J.W., 2007. Induction and function of lipocalin prostaglandin 
D synthase in host immunity. J Immunol 179, 2565-2575. 
Joo, M., Sadikot, R.T., 2012. PGD synthase and PGD2 in immune resposne. Mediators 
Inflamm 2012, 503128. 
Kanaoka, Y., Ago, H., Inagaki, E., Nanayama, T., Miyano, M., Kikuno, R., Fujii, Y., Eguchi, 
N., Toh, H., Urade, Y., Hayaishi, O., 1997. Cloning and crystal structure of hematopoietic 
prostaglandin D synthase. Cell 90, 1085-1095. 
Kim, N., Luster, A.D., 2007. Regulation of immune cells by eicosanoid receptors. 
ScientificWorldJournal 7, 1307-1328. 
Murata, T., Aritake, K., Tsubosaka, Y., Maruyama, T., Nakagawa, T., Hori, M., Hirai, H., 
Nakamura, M., Narumiya, S., Urade, Y., Ozaki, H., 2013. Anti-inflammatory role of PGD2 in 
acute lung inflammation and therapeutic application of its signal enhancement. Proc Natl 
Acad Sci U S A 110, 5205-5210. 
 20
Nagata, N., Fujimori, K., Okazaki, I., Oda, H., Eguchi, N., Uehara, Y., Urade, Y., 2009. De 
novo synthesis, uptake and proteolytic processing of lipocalin-type prostaglandin D synthase, 
beta-trace, in the kidneys. The FEBS journal 276, 7146-7158. 
Ogawa, M., Hirawa, N., Tsuchida, T., Eguchi, N., Kawabata, Y., Numabe, A., Negoro, H., 
Hakamada-Taguchi, R., Seiki, K., Umemura, S., Urade, Y., Uehara, Y., 2006. Urinary 
excretions of lipocalin-type prostaglandin D2 synthase predict the development of proteinuria 
and renal injury in OLETF rats. Nephrology, dialysis, transplantation : official publication of 
the European Dialysis and Transplant Association - European Renal Association 21, 924-934. 
Pouliot, M., Gilbert, C., Borgeat, P., Poubelle, P.E., Bourgoin, S., Creminon, C., Maclouf, J., 
McColl, S.R., Naccache, P.H., 1998. Expression and activity of prostaglandin endoperoxide 
synthase-2 in agonist-activated human neutrophils. FASEB J 12, 1109-1123. 
Rajakariar, R., Hilliard, M., Lawrence, T., Trivedi, S., Colville-Nash, P., Bellingan, G., 
Fitzgerald, D., Yaqoob, M.M., Gilroy, D.W., 2007. Hematopoietic prostaglandin D2 synthase 
controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyDelta12 
14 PGJ2. Proc Natl Acad Sci U S A 104, 20979-20984. 
Roca, F.J., Cayuela, M.L., Secombes, C.J., Meseguer, J., Mulero, V., 2007. Post-
transcriptional regulation of cytokine genes in fish: A role for conserved AU-rich elements 
located in the 3'-untranslated region of their mRNAs. Molecular immunology 44, 472-478. 
Roca, F.J., Sepulcre, M.A., Lopez-Castejon, G., Meseguer, J., Mulero, V., 2006. The colony-
stimulating factor-1 receptor is a specific marker of macrophages from the bony fish gilthead 
seabream. Molecular immunology 43, 1418-1423. 
Satoh, T., Moroi, R., Aritake, K., Urade, Y., Kanai, Y., Sumi, K., Yokozeki, H., Hirai, H., 
Nagata, K., Hara, T., Utsuyama, M., Hirokawa, K., Sugamura, K., Nishioka, K., Nakamura, 
M., 2006. Prostaglandin D2 plays an essential role in chronic allergic inflammation of the 
skin via CRTH2 receptor. J Immunol 177, 2621-2629. 
Sepulcre, M.P., Lopez-Castejon, G., Meseguer, J., Mulero, V., 2007. The activation of 
gilthead seabream professional phagocytes by different PAMPs underlines the behavioural 
diversity of the main innate immune cells of bony fish. Molecular immunology 44, 2009-
2016. 
Sepulcre, M.P., Lopez-Munoz, A., Angosto, D., Garcia-Alcazar, A., Meseguer, J., Mulero, V., 
2011. TLR agonists extend the functional lifespan of professional phagocytic granulocytes in 
the bony fish gilthead seabream and direct precursor differentiation towards the production of 
granulocytes. Molecular immunology 48, 846-859. 
Sepulcre, M.P., Pelegrin, P., Mulero, V., Meseguer, J., 2002. Characterisation of gilthead 
seabream acidophilic granulocytes by a monoclonal antibody unequivocally points to their 
involvement in fish phagocytic response. Cell and tissue research 308, 97-102. 
Shibata, T., Kondo, M., Osawa, T., Shibata, N., Kobayashi, M., Uchida, K., 2002. 15-deoxy-
delta 12,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory 
processes. J Biol Chem 277, 10459-10466. 
Simmons, D.L., Botting, R.M., Hla, T., 2004. Cyclooxygenase isozymes: the biology of 
prostaglandin synthesis and inhibition. Pharmacological reviews 56, 387-437. 
Takeshita, K., Yamasaki, T., Nagao, K., Sugimoto, H., Shichijo, M., Gantner, F., Bacon, 
K.B., 2004. CRTH2 is a prominent effector in contact hypersensitivity-induced neutrophil 
inflammation. Int Immunol 16, 947-959. 
Taniike, M., Mohri, I., Eguchi, N., Beuckmann, C.T., Suzuki, K., Urade, Y., 2002. 
Perineuronal oligodendrocytes protect against neuronal apoptosis through the production of 
lipocalin-type prostaglandin D synthase in a genetic demyelinating model. J Neurosci 22, 
4885-4896. 
Uehara, Y., Makino, H., Seiki, K., Urade, Y., 2009. Urinary excretions of lipocalin-type 
prostaglandin D synthase predict renal injury in type-2 diabetes: a cross-sectional and 
 21
prospective multicentre study. Nephrology, dialysis, transplantation : official publication of 
the European Dialysis and Transplant Association - European Renal Association 24, 475-482. 
Urade, Y., Eguchi, N., 2002. Lipocalin-type and hematopoietic prostaglandin D synthases as a 
novel example of functional convergence. Prostaglandins & other lipid mediators 68-69, 375-
382. 
Urade, Y., Hayaishi, O., 2000. Prostaglandin D synthase: structure and function. Vitamins and 
hormones 58, 89-120. 
Urade, Y., Kitahama, K., Ohishi, H., Kaneko, T., Mizuno, N., Hayaishi, O., 1993. Dominant 
expression of mRNA for prostaglandin D synthase in leptomeninges, choroid plexus, and 
oligodendrocytes of the adult rat brain. Proc Natl Acad Sci U S A 90, 9070-9074. 
Urade, Y., Tanaka, T., Eguchi, N., Kikuchi, M., Kimura, H., Toh, H., Hayaishi, O., 1995. 
Structural and functional significance of cysteine residues of glutathione-independent 
prostaglandin D synthase. Identification of Cys65 as an essential thiol. J Biol Chem 270, 
1422-1428. 
